Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

As government funding dries up, Pfizer expects to charge private payers $110+ for Covid-19 vaccine
Endpoints
Fri, 10/21/22 - 10:53 am
Tags:
Pfizer, BioNTech, payers, vaccines, COVID-19
Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing
BioSpace
Thu, 10/20/22 - 11:24 pm
Tags:
Erasca, Pfizer, ERAS-007, Ibrance, colorectal cancer
Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report
Fierce Pharma
Thu, 10/20/22 - 10:48 am
Tags:
Pfizer, Pharma CEOs, Albert Bourla, drug launches, COVID-19, vaccines
AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial
Fierce Biotech
Thu, 10/20/22 - 10:35 am
Tags:
AM-Pharma, clinical trials, kidney injury, Pfizer
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
BioSpace
Wed, 10/19/22 - 10:44 am
Tags:
Nucleome Therapeutics, funding, precision medicine, autoimmune diseases, Pfizer, JNJ, Merck KGaA, autoimmune disease
Pfizer takes Vyndaqel copay fight to Supreme Court, decrying 'staggeringly overbroad' anti-kickback rule
Fierce Pharma
Mon, 10/17/22 - 11:31 pm
Tags:
Pfizer, Supreme Court, kickbakcs, tafamidis, copays, Vyndaqel
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
Fri, 10/14/22 - 10:38 am
Tags:
FDA, Phanes, Pfizer, GSK, Regeneron, Eagle Pharmaceuticals, Galactin Therapeutics, BridgeBio, Gilead Sciences, Covis Pharma, scPharmaceuticals, XACT Robotics, BioMind Labs
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
Tags:
biopharma stocks, COVID-19, Eli Lilly, Bristol Myers Squibb, Merck, Daiichi Sankyo, Vertex Pharmaceuticals, Takeda, Neurocrine, Sarepta Therapeutics, Orion, Pfizer, GSK, Roche, Moderna Therapeutics, BeiGene, BioNTech, Novavax, CureVac
GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer
Fierce Biotech
Thu, 10/13/22 - 09:47 am
Tags:
GSK, RSV, vaccines, clinical trials, Pfizer, JNJ, Moderna Therapeutics, RSVPreF3
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Yahoo/Businesswire
Thu, 10/13/22 - 09:26 am
Tags:
Pfizer, BioNTech, clinical trials, COVID-19, vaccines, boosters, bivalent boosters
FDA authorizes Moderna and Pfizer-BioNTech Bivalent COVID vaccines for booster doses in younger age groups
Pharma Live
Wed, 10/12/22 - 10:36 am
Tags:
FDA, Pfizer, Moderna Therapeutics, BioNTech, vaccines, boosters, bivalent boosters, COVID-19, pediatric
FWIW, Pfizer exec denies company negotiated vaccine deal with Europe via text messages
Fierce Pharma
Tue, 10/11/22 - 04:14 pm
Tags:
Pfizer, Pharma CEOs, Albert Bourla, vaccines, COVID-19, Europe
After selling startups to Novo and Pfizer, Andera raises record €456M for latest life sciences fund
Fierce Biotech
Mon, 10/10/22 - 10:30 am
Tags:
Andera Partners, funding, life sciences, startups, Pfizer, Novo Nordisk, Europe, venture capital
From Africa to Australia and beyond, BioNTech's global mRNA ambitions take flight
Fierce Pharma
Fri, 10/7/22 - 10:49 am
Tags:
Pfizer, BioNTech, MRNA, Australia, COVID-19
Pfizer’s dealmaking continues as GBT, Biohaven acquisitions close
Medical Marketing and Media
Wed, 10/5/22 - 10:43 am
Tags:
Pfizer, M&A, Global Blood Therapeutics, Biohaven
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
Tags:
M&A, Pfizer, Global Blood Therapeutics, Amgen, ChemoCentryx, Novo Nordisk, Forma, Alcon, Aerie Pharmaceuticals, Gilead Sciences, MiroBio
With Pfizer sale in the rearview, Biohaven veers toward Kv7 platform following late-stage trial fails, delays
Fierce Biotech
Tue, 10/4/22 - 11:45 pm
Tags:
Pfizer, Biohaven, migraines, epilepsy
Pfizer’s PARP inhibitor combo treatment passes primary endpoint — but details are slim
Endpoints
Tue, 10/4/22 - 11:06 am
Tags:
Pfizer, Xtandi, Talzenna, PARP inhibitors, Medivation, clinical trials, prostate cancer
Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease
Fierce Biotech
Tue, 10/4/22 - 10:48 am
Tags:
Pfizer, Voyager Therapeutics, capsids, gene therapy
Alnylam's new Onpattro data raise fresh doubts in heart disease fight against Pfizer: analyst
Fierce Pharma
Mon, 10/3/22 - 11:41 pm
Tags:
Alnylam, Onpattro, Pfizer, ATTR-CM

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.